ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 670804 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 670804; 2) Community: the network communities that were significantly associated with the response to NSC 670804; 3) Molecule: the relationships between components within communities and NSC 670804; 4) MDR: the compounds that were significantly associated with the NSC 670804.

NSC Compound Enrichment Correlation
NSC 625495 Antimony, dibromo(1-piperidinecarbodithioato-S,S')-, (T-4)- 0.0392716453377541 0.0062674462
NSC 626778 Null 0.0392716453377541 0.038701687
NSC 668253 Null 0.0392716453377541 -0.058118239
NSC 105014 Cladribine 0.0403978426119736 -0.2495461
NSC 126228 Ethanesulfonic acid, compd. with m-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0403978426119736 0.035458341
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0403978426119736 -0.096421603
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0403978426119736 0.23064686
NSC 313681 Oxiperomide(USAN) 0.0403978426119736 0.035623764
NSC 40618 Cyclohexanone, 2,6-dibenzylidene- (8CI) 0.0403978426119736 -0.074397874
NSC 55236 Null 0.0403978426119736 -0.18419772
Total:32  Current:26    [First] [Prev] [Next] [Last]